| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.MP.4001793 |
| P698 | PubMed publication ID | 16432528 |
| P2093 | author name string | Gitlin M | |
| P2860 | cites work | The use of nimodipine in the treatment of mood disorders | Q73634858 |
| Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group | Q73688073 | ||
| Venlafaxine monotherapy in women with bipolar II and unipolar major depression | Q73897688 | ||
| A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 | ||
| Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode | Q77469646 | ||
| Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years | Q81333670 | ||
| Clinical factors associated with treatment noncompliance in euthymic bipolar patients | Q28138392 | ||
| Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial | Q28143204 | ||
| Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 | ||
| Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression | Q28247703 | ||
| Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial | Q28259736 | ||
| Pramipexole for bipolar II depression: a placebo-controlled proof of concept study | Q28268655 | ||
| Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 | ||
| Omega-3 Eicosapentaenoic Acid in Bipolar Depression | Q30054139 | ||
| An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). | Q30482552 | ||
| Donepezil in treatment-resistant bipolar disorder. | Q33673659 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? | Q33942947 | ||
| A review of psychosocial outcome in patients with bipolar disorder | Q34176007 | ||
| Calcium channel antagonists for the treatment of bipolar disorder | Q34185322 | ||
| Lamotrigine: a review of its use in bipolar disorder | Q34228876 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis | Q34304735 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group | Q34514128 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. | Q34744028 | ||
| Mood stabilizer combinations: a review of safety and efficacy | Q34744469 | ||
| Continuation and maintenance ECT in treatment-resistant bipolar disorder | Q35079494 | ||
| Antidepressant properties of anticonvulsant drugs for bipolar disorder | Q35086226 | ||
| Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options | Q35101637 | ||
| Advances in the pharmacologic treatment of bipolar depression | Q35111576 | ||
| Antidepressants in bipolar disorder: the case for caution | Q35592492 | ||
| Psychological treatment for bipolar disorders--a review of randomised controlled trials. | Q35775027 | ||
| A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients | Q35947317 | ||
| The current status of psychological treatments in bipolar disorders: a systematic review of relapse prevention | Q35947322 | ||
| Treatment of bipolar depression | Q36096470 | ||
| The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. | Q36192638 | ||
| Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation | Q39264353 | ||
| Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy | Q40744586 | ||
| Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience | Q40808838 | ||
| Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics | Q40851029 | ||
| Treatment-resistant bipolar depression | Q41127918 | ||
| Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. | Q42537403 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
| A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. | Q42625302 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Low doses of clozapine may stabilize treatment-resistant bipolar patients | Q42640390 | ||
| Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder | Q42650683 | ||
| Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study | Q42664825 | ||
| An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients | Q42682051 | ||
| Tiagabine in treatment refractory bipolar disorder: a clinical case series. | Q42690598 | ||
| Relapse and impairment in bipolar disorder | Q43514252 | ||
| Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. | Q43942064 | ||
| Verapamil treatment for women with bipolar disorder | Q43975773 | ||
| Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study | Q44103185 | ||
| Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? | Q44231406 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study. | Q44418358 | ||
| Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation | Q44452755 | ||
| A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity | Q44477346 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design | Q44559995 | ||
| Prophylactic effect of phenytoin in bipolar disorder: a controlled study | Q44667923 | ||
| Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study | Q44675680 | ||
| Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate | Q44783521 | ||
| Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone | Q44824135 | ||
| A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 | ||
| Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study | Q44977887 | ||
| Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects | Q45145894 | ||
| Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study | Q45157444 | ||
| A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 | ||
| Divalproex in the treatment of bipolar depression: a placebo-controlled study | Q46394405 | ||
| A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder | Q46503060 | ||
| Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. | Q46507616 | ||
| Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction | Q46516221 | ||
| A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 | ||
| Open-label adjunctive topiramate in the treatment of unstable bipolar disorder | Q46639807 | ||
| Double-blind, placebo-controlled pilot study of mexiletine for acute mania or hypomania | Q46701500 | ||
| Calcium antagonists in mania: a double-blind study of verapamil | Q48316227 | ||
| Use of topiramate, a new anti-epileptic as a mood stabilizer | Q48777380 | ||
| Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. | Q50877463 | ||
| Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. | Q51938690 | ||
| Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. | Q51990338 | ||
| Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 | ||
| Treatment of refractory depression with high-dose thyroxine. | Q52995440 | ||
| Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. | Q53017548 | ||
| The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. | Q54027554 | ||
| A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 | ||
| Effectiveness of the combination verapamil and chlorpromazine in the treatment of severe manic or mixed patients | Q57730600 | ||
| A Preliminary Open-Label Study of Zonisamide Treatment for Bipolar Depression in 10 Patients | Q59792454 | ||
| Superiority of Lithium Over Verapamil in Mania | Q60473475 | ||
| Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania | Q61764441 | ||
| Electroconvulsive treatment compared with lithium in the management of manic states | Q69921146 | ||
| Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment | Q70665552 | ||
| Integrated family and individual therapy for bipolar disorder: results of a treatment development study | Q73116736 | ||
| A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder | Q73236325 | ||
| Phenytoin as an antimanic anticonvulsant: a controlled study | Q73501981 | ||
| Mexiletine in treatment-resistant bipolar disorder | Q73526349 | ||
| P433 | issue | 3 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 227-240 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Treatment-resistant bipolar disorder | |
| P478 | volume | 11 |
| Q34595181 | A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania |
| Q36944534 | A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania |
| Q55311491 | Aberrant Neural Activity in Patients With Bipolar Depressive Disorder Distinguishing to the Unipolar Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study. |
| Q36754499 | Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment |
| Q87080024 | Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania? |
| Q46382585 | Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum |
| Q47667767 | Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications |
| Q28751133 | Bipolar disorder: candidate drug targets |
| Q37704228 | Can cycles of chills and fever resolve bipolar disorder mania? |
| Q37091444 | Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone |
| Q46876230 | Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice |
| Q24186084 | Clozapine augmentation for treatment-resistant schizoaffective disorder |
| Q38728298 | Deep brain stimulation for bipolar disorder-review and outlook |
| Q64067011 | Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement |
| Q64266553 | Evolution in the Treatment of Psychiatric Disorders: From Psychosurgery to Psychopharmacology to Neuromodulation |
| Q36822743 | Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment |
| Q34130349 | Fats and factors: lipid profiles associate with personality factors and suicidal history in bipolar subjects |
| Q88179991 | Functional Connectivity Between Anterior Insula and Key Nodes of Frontoparietal Executive Control and Salience Networks Distinguish Bipolar Depression From Unipolar Depression and Healthy Control Subjects |
| Q34398007 | Glutamatergic modulators: the future of treating mood disorders? |
| Q34080310 | Integrated neurobiology of bipolar disorder |
| Q91302159 | Intervening early in bipolar disorder in young people: a review of the clinical staging model |
| Q39305705 | Is Mania the Hypertension of the Mood? Discussion of A Hypothesis |
| Q28076893 | Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review |
| Q92674172 | Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study |
| Q90401057 | Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning |
| Q36929705 | New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania |
| Q98287897 | Prevalence and clinical correlates of residual symptoms in remitted patients with bipolar disorder: An exploratory study |
| Q33573983 | Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder |
| Q42345089 | Response to letters by Baethge et al. and Martino et al. |
| Q30438816 | SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties |
| Q50779681 | Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study. |
| Q38179926 | Tamoxifen use for the management of mania: a review of current preclinical evidence |
| Q35802177 | Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic |
| Q53413774 | Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases. |
| Q33593061 | The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment |
| Q34823805 | Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges |
Search more.